December 27, 2007 — The US Food and Drug Administration (FDA) has approved sapropterin dihydrochloride tablets for the adjunctive treatment of phenylketonuria, pantoprazole sodium delayed-release oral suspension for patients with gastroesophageal reflux disease unable to swallow tablets, and low-dose lopinavir/ritonavir 100-mg/25-mg tablets for use with other antiretroviral agents in the treatment of children with HIV infection.
Subscribe to:
Post Comments
(
Atom
)
0 comments :
Post a Comment